Single-Cell RNA Sequencing With Combined Use of Bulk RNA Sequencing to Reveal Cell Heterogeneity and Molecular Changes at Acute Stage of Ischemic Stroke in Mouse Cortex Penumbra Area

• DOI: 10.3389/fcell.2021.624711
• Publication Date: 2021-02-22T04:32:30Z
• Authors: Kang Guo; Jianing Luo; Dayun Feng; Lin Wu; Xin Wang; Li Xia; Kai Tao; Xun Wu; Wenxing Cui; Yixuan He; Bing Wang; Zhenwei Zhao; Zhiguo Zhang
• Keywords: Cell and Developmental Biology; 0303 health sciences; 03 medical and health sciences; QH301-705.5; ischemic stroke; microglia; general transcriptome; brain cortex penumbra; single-cell sequencing; Biology (General); cell survival; 3. Good health

Stroke has been the leading cause of adult morbidity and mortality over the past several years. After an ischemic stroke attack, many dormant or reversibly injured brain cells exist in the penumbra area. However, the pathological processes and unique cell information in the penumbra area of an acute ischemic stroke remain elusive. We applied unbiased single cell sequencing in combination with bulk RNA-seq analysis to investigate the heterogeneity of each cell type in the early stages of ischemic stroke and to detect early possible therapeutic targets to help cell survival. We used these analyses to study the mouse brain penumbra during this phase. Our results reveal the impact of ischemic stroke on specific genes and pathways of different cell types and the alterations of cell differentiation trajectories, suggesting potential pathological mechanisms and therapeutic targets. In addition to classical gene markers, single-cell genomics demonstrates unique information on subclusters of several cell types and metabolism changes in an ischemic stroke. These findings suggest that Gadd45b in microglia, Cyr61 in astrocytes, and Sgk3 in oligodendrocytes may play a subcluster-specific role in cell death or survival in the early stages of ischemic stroke. Moreover, RNA-scope multiplex in situ hybridization and immunofluorescence staining were applied to selected target gene markers to validate and confirm the existence of these cell subtypes and molecular changes during acute stage of ischemic stroke.